KollelBudget may earn a commission from purchases made via the links on this website, read our disclosure policy here. Thank you for your support!

 

Home > Uncategorized > TUMS Smoothies Berry Fusion Extra Strength Antacid Chewable Tablets for Heartburn Relief, 60 Tablets Only $2.54 – $2.84 + Free Shipping With Subscribe & Save From Amazon

TUMS Smoothies Berry Fusion Extra Strength Antacid Chewable Tablets for Heartburn Relief, 60 Tablets Only $2.54 – $2.84 + Free Shipping With Subscribe & Save From Amazon

December 18, 2019 Comments Off on TUMS Smoothies Berry Fusion Extra Strength Antacid Chewable Tablets for Heartburn Relief, 60 Tablets Only $2.54 – $2.84 + Free Shipping With Subscribe & Save From Amazon

UPDATE: Dead!

Amazon has the TUMS Smoothies Berry Fusion Extra Strength Antacid Chewable Tablets for Heartburn Relief, 60 Tablets marked down to $2.99, use “Subscribe & Save” to get free shipping and bring the price down to only $2.84.

If you have 5 or more “Subscribe & Save” subscriptions a month you will save 15% instead of 5% and your total will be only $2.54 + Free shipping.

  • TUMS Smoothies Extra Strength Berry Fusion antacids offer fast acting, extra strength heartburn relief so smooth, it’s fast
  • TUMS antacid tablets relieve heartburn, sour stomach, acid indigestion, and upset stomach associated with these symptoms
  • Delivers 50 percent more acid neutralizing power than TUMS Regular Strength chewable antacids
  • Comes in a smooth, delicious berry fusion flavor and goes to work in seconds
  • TUMS heartburn medicine is America’s number one antacid

TUMS Smoothies Berry Fusion Extra Strength Antacid Chewable Tablets for Heartburn Relief, 60 Tablets

 

Note: The price is accurate as of the time of posting, but Amazon’s prices are always changing, so make sure to check the price shown on Amazon when you are checking out, as that will be the price you are charged!

After your order processes you can to go to “Your Account” and click on “Manage Subscribe & Save” to cancel any future shipments

Comments are closed.